Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2021 | -13.81 Million USD | -1986.56% |
| 2020 | -662 Thousand USD | 92.69% |
| 2019 | -9.05 Million USD | -1001.19% |
| 2018 | 1 Million USD | -87.77% |
| 2017 | 8.21 Million USD | 432.6% |
| 2016 | 1.54 Million USD | 161.06% |
| 2015 | -2.52 Million USD | -257.45% |
| 2014 | 1.6 Million USD | -57.4% |
| 2013 | 3.76 Million USD | -51.94% |
| 2012 | 7.84 Million USD | 185.92% |
| 2011 | 2.74 Million USD | 307.1% |
| 2010 | -1.32 Million USD | 50.71% |
| 2009 | -2.68 Million USD | 46.56% |
| 2008 | -5.02 Million USD | 37.64% |
| 2007 | -8.06 Million USD | -33.58% |
| 2006 | -6.03 Million USD | -135.7% |
| 2005 | -2.56 Million USD | 73.55% |
| 2004 | -9.67 Million USD | -61.27% |
| 2003 | -6 Million USD | -32.21% |
| 2002 | -4.53 Million USD | -156.88% |
| 2001 | -1.76 Million USD | -162.95% |
| 2000 | -672 Thousand USD | 56.95% |
| 1999 | -1.56 Million USD | 56.64% |
| 1998 | -3.6 Million USD | -1000.0% |
| 1997 | 400 Thousand USD | 113.33% |
| 1996 | -3 Million USD | -328.57% |
| 1995 | -700 Thousand USD | 81.08% |
| 1994 | -3.7 Million USD | 17.78% |
| 1993 | -4.5 Million USD | -40.63% |
| 1992 | -3.2 Million USD | -357.14% |
| 1991 | -700 Thousand USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 Q1 | -8.52 Million USD | 38.28% |
| 2022 Q3 | -26 Thousand USD | 99.3% |
| 2022 Q2 | -3.73 Million USD | 56.2% |
| 2021 Q4 | -13.81 Million USD | 21.01% |
| 2021 FY | -13.81 Million USD | -1986.56% |
| 2021 Q1 | -22.26 Million USD | -4100.0% |
| 2021 Q2 | -20.37 Million USD | 8.46% |
| 2021 Q3 | -17.48 Million USD | 14.18% |
| 2020 Q1 | -4.65 Million USD | 48.61% |
| 2020 Q3 | -3.27 Million USD | -23.61% |
| 2020 Q2 | -2.65 Million USD | 43.04% |
| 2020 FY | -662 Thousand USD | 92.69% |
| 2020 Q4 | -530 Thousand USD | 83.83% |
| 2019 Q1 | 13.1 Million USD | 1204.08% |
| 2019 Q4 | -9.05 Million USD | -139.61% |
| 2019 FY | -9.05 Million USD | -1001.19% |
| 2019 Q2 | 22.01 Million USD | 67.96% |
| 2019 Q3 | 22.86 Million USD | 3.87% |
| 2018 Q2 | -489 Thousand USD | 94.59% |
| 2018 Q1 | -9.04 Million USD | -210.05% |
| 2018 FY | 1 Million USD | -87.77% |
| 2018 Q4 | 1 Million USD | -89.98% |
| 2018 Q3 | 10.02 Million USD | 2150.51% |
| 2017 Q1 | -21.72 Million USD | -1507.97% |
| 2017 FY | 8.21 Million USD | 432.6% |
| 2017 Q4 | 8.21 Million USD | 1616.24% |
| 2017 Q3 | -542 Thousand USD | 95.72% |
| 2017 Q2 | -12.66 Million USD | 41.69% |
| 2016 Q1 | -814 Thousand USD | 67.79% |
| 2016 Q2 | -10.37 Million USD | -1174.08% |
| 2016 Q3 | -4.41 Million USD | 57.42% |
| 2016 Q4 | 1.54 Million USD | 134.94% |
| 2016 FY | 1.54 Million USD | 161.06% |
| 2015 Q3 | -1.06 Million USD | 75.68% |
| 2015 FY | -2.52 Million USD | -257.45% |
| 2015 Q1 | 3.27 Million USD | 104.3% |
| 2015 Q4 | -2.52 Million USD | -138.17% |
| 2015 Q2 | -4.36 Million USD | -233.03% |
| 2014 Q4 | 1.6 Million USD | 417.71% |
| 2014 Q3 | -505.18 Thousand USD | -111.06% |
| 2014 Q2 | 4.56 Million USD | -4.4% |
| 2014 Q1 | 4.77 Million USD | 26.75% |
| 2014 FY | 1.6 Million USD | -57.4% |
| 2013 Q1 | 7.61 Million USD | -2.82% |
| 2013 Q3 | 4.38 Million USD | -7.15% |
| 2013 Q2 | 4.72 Million USD | -37.96% |
| 2013 FY | 3.76 Million USD | -51.94% |
| 2013 Q4 | 3.76 Million USD | -14.15% |
| 2012 Q1 | 6.89 Million USD | 151.6% |
| 2012 Q4 | 7.84 Million USD | -17.06% |
| 2012 Q3 | 9.45 Million USD | 19.31% |
| 2012 Q2 | 7.92 Million USD | 14.84% |
| 2012 FY | 7.84 Million USD | 185.92% |
| 2011 FY | 2.74 Million USD | 307.1% |
| 2011 Q4 | 2.74 Million USD | 34.94% |
| 2011 Q3 | 2.03 Million USD | 39.56% |
| 2011 Q2 | 1.45 Million USD | 654.4% |
| 2011 Q1 | 193 Thousand USD | 114.58% |
| 2010 Q4 | -1.32 Million USD | 0.08% |
| 2010 Q1 | -1.84 Million USD | 31.38% |
| 2010 FY | -1.32 Million USD | 50.71% |
| 2010 Q2 | -1.47 Million USD | 20.02% |
| 2010 Q3 | -1.32 Million USD | 10.11% |
| 2009 FY | -2.68 Million USD | 46.56% |
| 2009 Q1 | -4.31 Million USD | 14.07% |
| 2009 Q2 | -3.55 Million USD | 17.81% |
| 2009 Q3 | -3.25 Million USD | 8.39% |
| 2009 Q4 | -2.68 Million USD | 17.4% |
| 2008 Q1 | -6.84 Million USD | 15.14% |
| 2008 Q2 | -5.5 Million USD | 19.5% |
| 2008 Q4 | -5.02 Million USD | 9.23% |
| 2008 FY | -5.02 Million USD | 37.64% |
| 2008 Q3 | -5.53 Million USD | -0.56% |
| 2007 FY | -8.06 Million USD | -33.58% |
| 2007 Q2 | -8.64 Million USD | 14.21% |
| 2007 Q4 | -8.06 Million USD | 7.48% |
| 2007 Q3 | -8.71 Million USD | -0.78% |
| 2007 Q1 | -10.07 Million USD | -67.0% |
| 2006 Q2 | -4.89 Million USD | 2.72% |
| 2006 Q1 | -5.03 Million USD | -96.6% |
| 2006 FY | -6.03 Million USD | -135.7% |
| 2006 Q4 | -6.03 Million USD | -27.19% |
| 2006 Q3 | -4.74 Million USD | 3.1% |
| 2005 Q1 | -2.59 Million USD | 73.15% |
| 2005 Q4 | -2.56 Million USD | 9.12% |
| 2005 Q2 | -2.64 Million USD | -1.77% |
| 2005 FY | -2.56 Million USD | 73.55% |
| 2005 Q3 | -2.81 Million USD | -6.5% |
| 2004 Q3 | -9.8 Million USD | 2.92% |
| 2004 FY | -9.67 Million USD | -61.27% |
| 2004 Q1 | -10.62 Million USD | -76.97% |
| 2004 Q2 | -10.09 Million USD | 4.94% |
| 2004 Q4 | -9.67 Million USD | 1.24% |
| 2003 FY | -6 Million USD | -32.21% |
| 2003 Q4 | -6 Million USD | -6.93% |
| 2003 Q3 | -5.61 Million USD | 2.2% |
| 2003 Q2 | -5.73 Million USD | -31.52% |
| 2003 Q1 | -4.36 Million USD | 3.88% |
| 2002 Q2 | -3.13 Million USD | -19.5% |
| 2002 Q1 | -2.62 Million USD | -48.56% |
| 2002 FY | -4.53 Million USD | -156.88% |
| 2002 Q4 | -4.53 Million USD | -25.32% |
| 2002 Q3 | -3.62 Million USD | -15.46% |
| 2001 Q3 | -1.79 Million USD | 4.78% |
| 2001 Q2 | -1.88 Million USD | 28.88% |
| 2001 Q1 | -2.64 Million USD | -294.2% |
| 2001 FY | -1.76 Million USD | -162.95% |
| 2001 Q4 | -1.76 Million USD | 1.51% |
| 2000 Q4 | -672 Thousand USD | 69.37% |
| 2000 Q2 | -2.97 Million USD | 39.95% |
| 2000 Q1 | -4.94 Million USD | -217.04% |
| 2000 FY | -672 Thousand USD | 56.95% |
| 2000 Q3 | -2.19 Million USD | 26.18% |
| 1999 Q3 | -4 Million USD | -73.91% |
| 1999 FY | -1.56 Million USD | 56.64% |
| 1999 Q1 | -3.6 Million USD | 0.0% |
| 1999 Q2 | -2.3 Million USD | 36.11% |
| 1999 Q4 | -1.56 Million USD | 60.98% |
| 1998 Q2 | -6.9 Million USD | 30.3% |
| 1998 Q4 | -3.6 Million USD | 20.0% |
| 1998 Q3 | -4.5 Million USD | 34.78% |
| 1998 Q1 | -9.9 Million USD | -2575.0% |
| 1998 FY | -3.6 Million USD | -1000.0% |
| 1997 Q2 | -1.7 Million USD | 63.83% |
| 1997 Q3 | -400 Thousand USD | 76.47% |
| 1997 Q4 | 400 Thousand USD | 200.0% |
| 1997 FY | 400 Thousand USD | 113.33% |
| 1997 Q1 | -4.7 Million USD | -56.67% |
| 1996 Q2 | -4.3 Million USD | -2.38% |
| 1996 Q3 | -4.2 Million USD | 2.33% |
| 1996 Q4 | -3 Million USD | 28.57% |
| 1996 FY | -3 Million USD | -328.57% |
| 1996 Q1 | -4.2 Million USD | -500.0% |
| 1995 FY | -700 Thousand USD | 81.08% |
| 1995 Q4 | -700 Thousand USD | 0.0% |
| 1994 Q2 | -4 Million USD | 4.76% |
| 1994 Q3 | -11.5 Million USD | -187.5% |
| 1994 FY | -3.7 Million USD | 17.78% |
| 1994 Q4 | -3.7 Million USD | 67.83% |
| 1994 Q1 | -4.2 Million USD | 6.67% |
| 1993 Q2 | -5.2 Million USD | -100.0% |
| 1993 Q4 | -4.5 Million USD | 0.0% |
| 1993 Q3 | -4.5 Million USD | 13.46% |
| 1993 FY | -4.5 Million USD | -40.63% |
| 1993 Q1 | -2.6 Million USD | 18.75% |
| 1992 FY | -3.2 Million USD | -357.14% |
| 1992 Q3 | -4 Million USD | -900.0% |
| 1992 Q4 | -3.2 Million USD | 20.0% |
| 1992 Q2 | 500 Thousand USD | 200.0% |
| 1992 Q1 | -500 Thousand USD | 28.57% |
| 1991 FY | -700 Thousand USD | 0.0% |
| 1991 Q4 | -700 Thousand USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acutus Medical, Inc. | 12.27 Million USD | 212.493% |
| Biotricity, Inc. | 23.09 Million USD | 159.815% |
| Cell MedX Corp. | 244.05 Thousand USD | 5759.883% |
| Dynatronics Corporation | 6.2 Million USD | 322.645% |
| Nemaura Medical Inc. | 9.92 Million USD | 239.174% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1181.137% |
| RetinalGenix Technologies Inc. | 506.53 Thousand USD | 2826.964% |
| Sonendo, Inc. | 26.34 Million USD | 152.437% |
| Telesis Bio, Inc. | 32.63 Million USD | 142.326% |
| Talis Biomedical Corporation | -57.06 Million USD | 75.794% |